Does OCRELIZUMAB Cause Covid-19 pneumonia? 669 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 669 reports of Covid-19 pneumonia have been filed in association with OCRELIZUMAB (OCREVUS). This represents 1.2% of all adverse event reports for OCRELIZUMAB.
669
Reports of Covid-19 pneumonia with OCRELIZUMAB
1.2%
of all OCRELIZUMAB reports
92
Deaths
478
Hospitalizations
How Dangerous Is Covid-19 pneumonia From OCRELIZUMAB?
Of the 669 reports, 92 (13.8%) resulted in death, 478 (71.4%) required hospitalization, and 14 (2.1%) were considered life-threatening.
Is Covid-19 pneumonia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCRELIZUMAB. However, 669 reports have been filed with the FAERS database.
What Other Side Effects Does OCRELIZUMAB Cause?
Covid-19 (11,454)
Fatigue (5,704)
Urinary tract infection (3,618)
Headache (3,036)
Multiple sclerosis (2,609)
Asthenia (2,509)
Nasopharyngitis (2,479)
Gait disturbance (2,384)
Pneumonia (2,333)
Pain (2,327)
What Other Drugs Cause Covid-19 pneumonia?
RITUXIMAB (1,489)
DEXAMETHASONE (758)
LENALIDOMIDE (750)
PREDNISONE (749)
TACROLIMUS (622)
MYCOPHENOLATE MOFETIL (594)
PREDNISOLONE (479)
METHOTREXATE (472)
CYCLOPHOSPHAMIDE (430)
METHYLPREDNISOLONE (347)
Which OCRELIZUMAB Alternatives Have Lower Covid-19 pneumonia Risk?
OCRELIZUMAB vs OCRIPLASMIN
OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE
OCRELIZUMAB vs OCTREOTIDE
OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE